Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,371 across all filing types
Latest filing 2025-04-28 Environmental & Social …
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024
Environmental & Social Information Classification · 1% confidence The document is titled “Environmental, Social and Governance Report 2024” for CStone Pharmaceuticals and contains detailed disclosures on ESG strategy, governance structure, environmental protection metrics, social responsibility initiatives, and sustainability data – matching the definition for Environmental & Social Information (ESG) reports. It is not a simple announcement or part of another filing but a full standalone ESG report.
2025-04-28 English
2024 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is explicitly titled '2024年度報告 Annual Report' and contains comprehensive sections typical of an annual report, including 'Corporate Information', 'Financial Highlights', 'Management Discussion and Analysis', 'Independent Auditor's Report', and full 'Consolidated Financial Statements'. It covers the fiscal year ended December 31, 2024, and provides detailed financial and operational performance data, fitting the definition of a 10-K (Annual Report). FY 2024
2025-04-28 English
(Update) Final Dividend for the Year Ended 31 December 2024
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement on the Hong Kong Exchange platform detailing the final cash dividend for the year ended 31 December 2024. It specifies the dividend amount per share, dividend type, ex-dividend date, record date, payment date, and related shareholder approval information. These characteristics match the definition of a Notice of Dividend Amount (DIV).
2025-04-28 English
Form of Proxy for Use at the Annual General Meeting for the Year Ended 31 December 2024 to be held on Friday, 30 May 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for use at the Annual General Meeting, which is material sent to shareholders to request votes and appoint proxies. This falls under Proxy Solicitation & Information Statement (PSI).
2025-04-28 English
Circular
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a detailed ‘circular’ issued to shareholders ahead of the 2024 Annual General Meeting, containing proposals (renewal of liability insurance, auditor reappointment, financing guarantees, amendments to articles, share issue and repurchase mandates, director appointments), proxy instructions, meeting notice and appendices. This is not the AGM presentation itself or the annual report, but proxy solicitation and information materials sent to shareholders to request votes at the AGM. Therefore it matches the Proxy Solicitation & Information Statement category (PSI).
2025-04-28 English
NOTICE OF 2024 ANNUAL GENERAL MEETING
AGM Information Classification · 1% confidence The document is clearly a formal Notice of the 2024 Annual General Meeting, detailing the time, venue, agenda items (resolutions), proxy procedures, record dates, and related meeting arrangements. This falls squarely under AGM Information (AGM-R), which covers AGM notices and materials related to the Annual General Meeting itself.
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.